Health System

FDA approves Ivacaftor and Exenatide extended-release injection.

A survey of new Rx, new generic, and new OTC products

FDA talks with stakeholders about the growing number of deaths from opioid drug overdoses.

As pharmacists and others wait to learn ACA's fate in the U.S. Supreme Court, the issue of provider status under the Social Security Act continues to worry those seeking to expand into MTM and other clinical services.

A round-up of OTC products to manage allergies

Four pharmacies have sued HHS and CMS to halt what they call a violation of federal Medicare Part D statute.

Part 2 of this article discusses assistive devices that help impaired diabetes patients self-administer medication.

Healthcare industry experts discuss the pros and cons.

New CAD/ACS antiplatelet agents a mixed bag.

Readers speak out about what got retail pharmacy where it is today; why the term "doctor" is like the curl in a pig's tail; and where the MD should put that vial of ropivacaine.

The readmission rate for congestive heart failure patients was reduced by more than 50% after Morris Hospital in Morris, Ill., implemented a pilot medication reconciliation program.

Pharmacists save the medical system millions of dollars every single day by keeping people away from the ER. They don't say thank you. And they don't even know that we're front-line money-savers.

Sanofi US recently introduced a blood glucose meter that directly connects to the iPhone and the iPod touch, and communicates results with caregivers and healthcare teams.

What's different in your drug stores this month? A children's sugar-free multivitamin drink. An organizer for patients taking multiple medications. A non-fish oil omega-6 fatty acid supplement. A smaller acetaminophen suppository for infants. Heartburn relief plus breath freshening in a single product. A convenient stain-removing strip option. And there are even more new over-the-counter items featured in the print edition of Drug Topics.

Pharmacists play a vital role in FDA's "new paradigm" for a third class of drugs, according to the National Association of Chain Drug Stores.

Hospira is voluntarily recalling one lot of hydromorphone injection, USP, 1 mg/mL (C-II), 1-mL fill in 2.5-mL Carpuject, NDC 0409-1283-31, after complaints that a single Carpuject contained more than the 1-mL labeled fill volume, according to a press release posted on the FDA website.

Bariatric surgery plus medical therapy may be a useful strategy for managing uncontrolled diabetes, according to the results of a recent study published in the New England Journal of Medicine.

Children with juvenile idiopathic arthritis were at twice the risk of infection compared with children with attention-deficit hyperactivity disorder, according to a study published May 1 in Arthritis & Rheumatism.

The National Association of Boards of Pharmacy wants to vet internet pharmacies that will be applying for a .pharmacy domain name and to warn about how rogue internet sites are preying on consumers' fears about drug shortages.

The Drug Enforcement Administration?s National Prescription Drug Take-Back Day produced a record-breaking amount of unused medications.

Connecticut's legislature passed a bill this weekend that would legalize the use of medical marijuana in the state. While several other states have similar laws, Connecticut is putting more restrictions on the dispensing of the drug.

The percentage of Americans who are able to quit smoking has decreased over the past 2 decades, according to a new report, but retail pharmacists can play a key role in reversing that trend, one of the leaders of a team of tobacco researchers told Drug Topics.

Phthalate metabolites, chemicals commonly used in plastics, cosmetics, and pharmaceuticals, were linked to an increased risk for the development of type 2 diabetes in the elderly, a recent study found.

The supplementation with omega-3 fatty acids has no benefit in treating multiple sclerosis, according to a clinical trial that appeared in the JAMA's Archives of Neurology. However, researchers acknowledged the randomized controlled trial was underpowered.

A set of 11 evidence-based recommendations for managing pain with pharmacotherapy in patients suffering inflammatory arthritis were reported by an international panel online March 24 in Rheumatology.